Approach to the Renal Mass

Someone hands you a CT and says "there's something on the kidney." Your heart rate ticks up, because "something on the kidney" covers everything from a water balloon nobody should care about to a cancer that needs surgery. The good news: there is a tidy decision tree that gets you from panic to a plan, and it mostly comes down to a handful of questions asked in order. The tree is the ACR white paper on the incidental renal mass, with Bosniak v2019 bolted on for the cystic branch. Let me walk you through the road.

First, the two ideas everything hangs on

Picture the kidney as a sponge with plumbing. A cyst is a little water balloon sitting in that sponge: sharply marginated, thin-walled, filled with fluid that measures near water on the Hounsfield scale. A solid mass is made of actual tissue, denser than water, and crucially it has a blood supply.

That blood supply is the whole game. To know whether a lesion has one, you compare its attenuation before contrast and after contrast. If contrast, which travels in blood, flows into the lesion, the lesion gets denser: it enhances. Enhancement is the fingerprint of living, vascularized tissue, and tumors are nothing if not enthusiastically vascular. This is why a renal-mass protocol always includes a non-contrast series. Without the "before" picture you are guessing: a lesion sitting at 40 HU on a single post-contrast scan could be a dense benign cyst or a solid tumor, and you genuinely cannot tell from one snapshot.

The search pattern

Run every renal mass through these steps in this order. Each step has the finding to look for and the threshold that decides it.

1. Find it, measure it, count it, and size the kidney. Note the location (pole, anterior or posterior, exophytic or central) and the size in three planes. Note whether there is one mass or many; multiplicity pushes you toward cysts, angiomyolipomas in tuberous sclerosis, lymphoma, or metastases. For context, the median adult kidney at sonography is about 11.2 cm long on the left and 10.9 cm on the right, with median volumes of 146 cm³ and 134 cm³; a mass that dwarfs its kidney is a different conversation from a mass you needed a magnifier to find.

2. Look for fat. Drop a region of interest on any dark focus inside the mass. < −10 HU is macroscopic fat, and a fat-containing renal mass is an angiomyolipoma until proven otherwise. That page carries the referral thresholds (≥4 cm, or an aneurysm >0.5 cm, or symptoms at any size). Fat plus calcification is the exception that should make you nervous.

3. Ask whether it is homogeneous, then read the number. Homogeneity is the password for every shortcut. On unenhanced CT, a homogeneous mass at −10 to +20 HU is a simple cyst (Bosniak I) needing no further evaluation, and a homogeneous mass at ≥70 HU is almost always a hyperdense cyst (Bosniak II), also needing nothing. On a contrast-enhanced-only CT, −10 to +20 HU is still a simple cyst, and a homogeneous 21–30 HU mass on the portal venous phase is Bosniak II. A homogeneous mass at >20 and <70 HU unenhanced, or at >20 HU on a contrast-only scan outside that portal venous exception, is indeterminate and needs pre- and post-contrast characterization. A heterogeneous mass skips every shortcut and goes straight to step 5; renal cell carcinoma is almost always heterogeneous on unenhanced CT.

4. Decide whether it is too small to characterize. A well-circumscribed, homogeneous mass too small to measure accurately that looks visually much lower in attenuation than the parenchyma (or, unenhanced, much higher) is probably a benign cyst. If it needs an answer, MRI is preferred for masses <1.5 cm and for detecting enhancement in suspected hypovascular masses.

5. Get the pre/post pair and answer the enhancement question. With a renal-mass-protocol CT or MRI in hand, decide whether the mass, or any nodular part of it, enhances. Enhancement of the mass or of a nodular component is concerning for neoplasm.

6. If it is cystic, grade it (Bosniak v2019). Measure the thickest enhancing wall or septum and count the septa. Thin (≤2 mm) with no septa is class I; few (1–3) thin septa is class II; a smooth minimally thickened (3 mm) enhancing wall or septum, or many (≥4) thin enhancing septa, is class IIF; enhancing thick (≥4 mm) or irregular (≤3 mm obtusely margined protrusions) tissue is class III; an enhancing nodule (≥4 mm with obtuse margins, or any size with acute margins) is class IV. The step-by-step lives on the approach to the cystic renal mass.

7. If it is solid and enhancing with no fat, treat it as RCC until proven otherwise, and size it. Two benign impostors, oncocytoma and fat-poor angiomyolipoma, cannot be excluded on imaging, and size is your only prior: a solid mass is benign in about 40% under 1 cm, about 20% at 1–4 cm, and under 10% above 4 cm, and smaller cancers are more often indolent. Then stage it: confined to the kidney at ≤4 cm is T1a, >4 to ≤7 cm T1b, >7 to ≤10 cm T2a, >10 cm T2b; renal vein, pelvicalyceal, sinus fat, or perirenal fat extension is T3a; IVC below the diaphragm T3b, above it or into the caval wall T3c; beyond Gerota fascia, including the ipsilateral adrenal, T4. Look at the renal vein and IVC every single time. The subtypes and the full T table live on RCC subtypes and staging.

8. Check the priors before you write. A mass with no change in imaging features and average growth ≤3 mm per year for at least 5 years is stable and needs no further workup. Growth is ≥4 mm per year on average; morphologic change is any change in heterogeneity such as contour, attenuation, or number of septa.

When fat shows up, relax a little

Before you assume every solid mass is cancer, check for the one happy exception: fat. If you can confidently find macroscopic fat, a region of interest < −10 HU, inside a renal mass, you are almost certainly looking at an angiomyolipoma, a benign tumor made of vessels, muscle, and fat. Renal cell carcinoma essentially never contains macroscopic fat, so finding it is a strong reassurance.

The analogy I like: fat in a renal mass is like finding sprinkles baked into a muffin. Sprinkles mean someone made it for fun, not for a tumor board. (The asterisk: a rare RCC can contain fat when it has undergone osseous metaplasia, bone with fatty marrow, and those show calcification within the fat, so fatty lesions with calcium still deserve a careful look. In everyday practice, pure fat points hard toward benign.)

Sorting the in-betweens

Real life is messy, and plenty of lesions land in the awkward middle: a cyst with a slightly thick wall here, a couple of septa there. For cystic-appearing lesions we do not eyeball it and hope; Bosniak v2019 grades the wall, septa, and nodules in millimetres, from "ignore it" up to "this needs to come out." For lesions that are frankly solid and enhancing, the working assumption flips: RCC until proven otherwise, and the conversation moves toward biopsy, surveillance, ablation, or resection depending on size and the patient.

How you actually scan it

Characterizing a renal mass well usually means a multiphase study: an unenhanced baseline, then images at different times after contrast as the kidney enhances and then excretes. The phases matter because lesions reveal themselves at different moments; some enhance briskly and fade, others creep up slowly, and a hypovascular papillary tumor can be missed on a single early phase. The mechanics of those phases and their timing live in the CT and MR urography protocols. When a patient cannot get iodinated contrast, MRI steps in; it judges enhancement too, with subtraction imaging doing the "before and after" for you, and it is the ACR's preferred tool for masses <1.5 cm.

Normal versus abnormal at a glance

The one thing to carry out the door

Walk through any renal mass the same way every time: fat, then homogeneity and the number, then the pre/post pair, then cyst or solid. Salute the fat when you see it, let the −10 to +20 and ≥70 HU shortcuts close the balloons, hand the cystic gray zone to Bosniak, and treat a solid enhancing mass without fat as a cancer with a size and a stage. Do that, and "there's something on the kidney" stops being scary and becomes a checklist.